The COVID-19 pandemic has been one of the biggest challenges in modern history, and vaccination efforts have been at the forefront of the global response. With the emergence of new COVID-19 variants and the continued threat of seasonal flu, vaccine manufacturers are developing new solutions to protect people from these viruses.
In this episode of MedEvidence Monday Minute, Dr. Michael Koren introduces new research opportunities on a dual flu and COVID-19 vaccine.
Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center. On a personal note, Dr. Koren has a life-long interest in history, technology, Public Health, and music. He has written two musical plays.
More information and Participate in Clinical ResearchÂ
Original Air Date: April 3, 2023
Be a part of advancing science by participating in clinical research
Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired
Thank you for listening!
